LEADER 02328nam  2200637 a 450 
001 9910824979503321
005 20240516164252.0
010   $a1-280-66941-1
010   $a9786613646347
010   $a981-4338-68-0
035   $a(CKB)2550000000101415
035   $a(EBL)919103
035   $a(OCoLC)794328398
035   $a(SSID)ssj0000654709
035   $a(PQKBManifestationID)12238070
035   $a(PQKBTitleCode)TC0000654709
035   $a(PQKBWorkID)10661333
035   $a(PQKB)10161417
035   $a(MiAaPQ)EBC919103
035   $a(WSP)00002654
035   $a(Au-PeEL)EBL919103
035   $a(CaPaEBR)ebr10563560
035   $a(CaONFJC)MIL364634
035   $a(EXLCZ)992550000000101415
100   $a20120607d2012      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBoron and gadolinium neutron capture therapy for cancer treatment$b[electronic resource] /$fNarayan S. Hosmane ... [et al.]
205   $a1st ed.
210   $aSingapore $cWorld Scientific Pub. Co.$d2012
215   $a1 online resource (271 p.)
300   $aDescription based upon print version of record.
311   $a981-4338-67-2 
320   $aIncludes bibliographical references and index.
327   $aWhat is cancer? -- Principles of neutron capture therapy -- Major neutron capture therapy (NCT) drug prototypes -- Neutron sources for NCT -- NCT dosimetry and treatment planning -- Selected in vitro and in vivo studies -- Clinical trials -- Future perspectives for boron and gadolinium neutron capture therapies in cancer treatment -- Clinical state of BNCT by US Department of Energy (DOE) as at 1997.
606   $aCancer$xTreatment
606   $aBoron-neutron capture therapy
606   $aBoron
606   $aGadolinium
615  0$aCancer$xTreatment.
615  0$aBoron-neutron capture therapy.
615  0$aBoron.
615  0$aGadolinium.
676   $a616.9940642
700   $aHosmane$b Narayan S$0858251
701   $aHosmane$b Narayan S$0858251
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910824979503321
996   $aBoron and gadolinium neutron capture therapy for cancer treatment$94023547
997   $aUNINA